Clinical trial
Treating Severe Chronic Epstein-Barr Virus (EBV) Infection With EBV Specific…
NCT00058591 · Baylor College of Medicine, Other · Completed
Key facts
| NCT number | NCT00058591 |
|---|---|
| Title | Treating Severe Chronic Epstein-Barr Virus (EBV) Infection With EBV Specific Cytotoxic T Lymphocytes (CTLs) |
| Official title | Autologous EBV Specific CTLs for Therapy of Severe Chronic EBV Infection |
| Acronym | SCAEBV |
| Lead sponsor | Baylor College of Medicine, Other |
| Collaborators | The Methodist Hospital Research Institute Center for Cell and Gene Therapy, Baylor College of Medicine |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Epstein-Barr Virus Infections |
| Intervention type | Biological |
| Interventions | Intravenous injection of EBV specific CTLS |
| Enrollment | 13 |
| Start date | Jan 1, 2000 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Apr 9, 2003 |
| Last update posted | Jan 18, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: